Paraskevi Krashia
Rome, 00143, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Midbrain dopamine loss drives parvalbumin interneuron vulnerability through tissue plasminogen activator-linked perineuronal-net breakdown and hippocampal disinhibition.
Journal: Neurobiology of disease
Published: May 11, 2026
A spit for a tip in dementia diagnosis: Evidence from saliva for dementia with Lewy bodies.
Journal: Journal of Alzheimer's disease : JAD
Published: April 21, 2025
Upadacitinib regulates pain-related pathways and BDNF expression in human monocyte-derived microglial-like cells.
Journal: Brain, behavior, and immunity
Published: April 09, 2025
Optogenetic stimulation of midbrain dopaminergic neurons rescues hippocampal synaptic plasticity deficits in a mouse model of Alzheimer's disease.
Journal: Translational psychiatry
Published: March 25, 2025
Repetitive prefrontal tDCS activates VTA dopaminergic neurons, resulting in attenuation of Alzheimer's Disease-like deficits in Tg2576 mice.
Journal: Alzheimer's research & therapy
Published: February 17, 2025
Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer's Disease.
Journal: Molecular neurodegeneration
Published: January 13, 2025
Chemogenetic induction of CA1 hyperexcitability triggers indistinguishable autistic traits in asymptomatic mice differing in Ambra1 expression and sex.
Journal: Translational psychiatry
Published: May 16, 2024
How dopamine tunes parvalbumin interneurons in the hippocampus: new experimental observations in Alzheimer's disease.
Journal: Neural regeneration research
Published: March 22, 2024
Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer's Disease.
Journal: Translational neurodegeneration
Published: January 08, 2024
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer's Disease.
Journal: Molecular psychiatry
Published: July 28, 2023
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases.
Journal: Ageing research reviews
Published: November 07, 2022
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice.
Journal: Molecular neurodegeneration
Published: September 21, 2022
Last Updated: 09/26/2026